0.1% sodium lauryl sulfate
Sponsors
Dr. Reddy's Laboratories Limited, Zurex Pharma, Inc.
Conditions
Head LiceSurgical Site Infection
Phase 1
Dermal Safety Study to Evaluate the Sensitizing Potential of Abametapir Lotion
CompletedNCT02062073
Start: 2014-01-31End: 2014-06-30Updated: 2020-04-29
Safety Study to Evaluate the Cumulative Irritation Potential of Topically Applied ZuraPrep™ and ZuraPrep™ Without IPA
CompletedNCT02160574
Start: 2014-06-30End: 2014-09-30Updated: 2014-10-27